Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |